Arabic Arabic English English French French German German
dark

Scopus BioPharma Announces New Management Appointment Following Acquisition of Leading Immunotherapy Company

Scopus BioPharma Inc. today announced a new management appointment following its acquisition of Olimmune Inc. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

‘Wasfaty’ Service Activated in King Saud Medical City

Next Post

Sciwind Biosciences Appoints Dr. Weidong Zhong as Chief Strategy Officer and President of its US Subsidiary

Related Posts
Total
0
Share